John S Yordy

John S Yordy

UNVERIFIED PROFILE

Are you John S Yordy?   Register this Author

Register author
John S Yordy

John S Yordy

Publications by authors named "John S Yordy"

Are you John S Yordy?   Register this Author

20Publications

512Reads

47Profile Views

miR-125a-5p Functions as Tumor Suppressor microRNA And Is a Marker of Locoregional Recurrence And Poor prognosis in Head And Neck Cancer.

Neoplasia 2019 09 18;21(9):849-862. Epub 2019 Jul 18.

Department of Radiation Oncology, Division of Molecular Radiation Biology, UT Southwestern Medical Center, Dallas, TX 75390. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.neo.2019.06.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6642270PMC
September 2019

Phantom-to-clinic development of hypofractionated stereotactic body radiotherapy for early-stage glottic laryngeal cancer.

Med Dosim 2017 Summer;42(2):90-96. Epub 2017 Apr 21.

Department of Radiation Oncology, Simmons Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.meddos.2017.01.004DOI Listing
March 2018

A Phase I/II Study of Nab-Paclitaxel, Cisplatin, and Cetuximab With Concurrent Radiation Therapy for Locally Advanced Squamous Cell Cancer of the Head and Neck.

Cancer Invest 2017 Jan 28;35(1):23-31. Epub 2016 Nov 28.

f Department of Radiation Oncology , Harold C. Simmons Comprehensive Cancer Center, University of Texas at Southwestern Medical Center , Dallas , TX , USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1080/07357907.2016.1213275DOI Listing
January 2017

Targeted inhibition of histone deacetylases and hedgehog signaling suppress tumor growth and homologous recombination in aerodigestive cancers.

Am J Cancer Res 2015 15;5(4):1337-52. Epub 2015 Mar 15.

Division of Molecular Radiation Biology, Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas at Southwestern Medical Center Dallas, TX, USA ; Anchorage and Valley Radiation Therapy Center Anchorage, AK, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4473314PMC
June 2015

A retrospective analysis of tumor volumetric responses to five-fraction stereotactic radiotherapy for paragangliomas of the head and neck (glomus tumors).

Stereotact Funct Neurosurg 2014 7;92(3):153-9. Epub 2014 May 7.

Department of Radiation Oncology, Harold C. Simmons Cancer Center, University of Texas at Southwestern Medical Center, Dallas, Tex., USA.

View Article

Download full-text PDF

Source
https://www.karger.com/Article/FullText/360864
Publisher Site
http://dx.doi.org/10.1159/000360864DOI Listing
February 2015

Wavelet analysis in current cancer genome research: a survey.

IEEE/ACM Trans Comput Biol Bioinform 2013 Nov-Dec;10(6):1442-59

University of Texas Southwestern Medical Center, Dallas.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1109/TCBB.2013.134DOI Listing
September 2014

Isolated central nervous system progression on Crizotinib: an Achilles heel of non-small cell lung cancer with EML4-ALK translocation?

Cancer Biol Ther 2012 Dec 17;13(14):1376-83. Epub 2012 Sep 17.

Department of Radiation Oncology, Harold C. Simmons Comprehensive Cancer Center, University of Texas Southwestern Medical Center, Dallas, TX, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4161/cbt.22255DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3542227PMC
December 2012

Development of the M. D. Anderson Cancer Center gynecologic applicators for the treatment of cervical cancer: historical analysis.

Int J Radiat Oncol Biol Phys 2012 Mar 21;82(4):1445-53. Epub 2011 Sep 21.

Department of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390-9183, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.ijrobp.2011.05.029DOI Listing
March 2012

TP53 disruptive mutations lead to head and neck cancer treatment failure through inhibition of radiation-induced senescence.

Clin Cancer Res 2012 Jan 16;18(1):290-300. Epub 2011 Nov 16.

Department of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas 77030, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-11-2260DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3251726PMC
January 2012

Blasted cell line names.

Cancer Inform 2010 Oct 14;9:251-5. Epub 2010 Oct 14.

Department of Bioinformatics and Computational Biology, University of Texas M.D. Anderson Cancer Center, Houston, TX, USA.

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.4137/CIN.S5613
Publisher Site
http://dx.doi.org/10.4137/CIN.S5613DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2978931PMC
October 2010

Prognostic and functional significance of thromboxane synthase gene overexpression in invasive bladder cancer.

Cancer Res 2005 Dec;65(24):11581-7

Department of Pathology and Laboratory Medicine, Biochemistry Medical University of South Carolina, Charleston, 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/0008-5472.CAN-05-1622DOI Listing
December 2005

SP100 inhibits ETS1 activity in primary endothelial cells.

Oncogene 2005 Jan;24(5):916-31

Department of Pathology and Laboratory Medicine, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1208245DOI Listing
January 2005

SP100 expression modulates ETS1 transcriptional activity and inhibits cell invasion.

Oncogene 2004 Aug;23(39):6654-65

Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1207891DOI Listing
August 2004

EAPII interacts with ETS1 and modulates its transcriptional function.

Oncogene 2003 May;22(18):2699-709

Laboratory of Cancer Genomics, Hollings Cancer Center, Medical University of South Carolina, Charleston, SC 29425, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/sj.onc.1206374DOI Listing
May 2003